Haleon (LON:HLN) Given Underweight Rating at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their underweight rating on shares of Haleon (LON:HLN) in a research report report published on Friday morning, MarketBeat reports.

HLN has been the topic of a number of other reports. Berenberg Bank lowered their price target on shares of Haleon from GBX 503 to GBX 500 and set a “buy” rating on the stock in a report on Friday, August 8th. The Goldman Sachs Group reissued a “buy” rating and set a GBX 440 target price on shares of Haleon in a research note on Wednesday, September 10th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a GBX 370 target price on shares of Haleon in a research note on Friday. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of GBX 436.67.

Haleon Stock Up 1.4%

Shares of HLN stock opened at GBX 355.70 on Friday. Haleon has a twelve month low of GBX 325.10 and a twelve month high of GBX 419.50. The stock has a market cap of £31.68 billion, a P/E ratio of 21.30, a P/E/G ratio of 1.49 and a beta of 0.19. The stock has a 50 day moving average of GBX 347.67 and a 200 day moving average of GBX 369.66. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN) last issued its quarterly earnings data on Thursday, July 31st. The company reported GBX 8.90 EPS for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. As a group, sell-side analysts expect that Haleon will post 19.5033282 EPS for the current year.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s product portfolio spans six major categories – Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.